Acadian Asset Management LLC Purchases 69,147 Shares of CryoPort, Inc. $CYRX

Acadian Asset Management LLC raised its holdings in CryoPort, Inc. (NASDAQ:CYRX) by 14.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 548,842 shares of the company’s stock after buying an additional 69,147 shares during the period. Acadian Asset Management LLC owned about 1.09% of CryoPort worth $4,090,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Russell Investments Group Ltd. raised its stake in shares of CryoPort by 154.5% in the first quarter. Russell Investments Group Ltd. now owns 32,761 shares of the company’s stock worth $199,000 after purchasing an additional 19,886 shares during the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of CryoPort by 7.3% in the second quarter. Assenagon Asset Management S.A. now owns 1,090,511 shares of the company’s stock valued at $8,135,000 after acquiring an additional 73,949 shares in the last quarter. CWM LLC grew its position in CryoPort by 1,437.0% during the first quarter. CWM LLC now owns 11,328 shares of the company’s stock valued at $69,000 after buying an additional 10,591 shares during the period. Conestoga Capital Advisors LLC raised its holdings in shares of CryoPort by 55.9% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 110,557 shares of the company’s stock worth $825,000 after purchasing an additional 39,640 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of CryoPort in the second quarter valued at approximately $292,000. 92.90% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CYRX shares. Leerink Partnrs raised shares of CryoPort from a “hold” rating to a “strong-buy” rating in a report on Wednesday, August 6th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of CryoPort in a research note on Wednesday, October 8th. BTIG Research boosted their price objective on shares of CryoPort from $10.00 to $15.00 and gave the stock a “buy” rating in a research note on Thursday, September 18th. KeyCorp raised CryoPort from a “sector weight” rating to an “overweight” rating and set a $15.00 price objective on the stock in a research report on Wednesday, August 6th. Finally, Stephens began coverage on CryoPort in a research note on Tuesday, July 22nd. They issued an “overweight” rating and a $13.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, CryoPort presently has a consensus rating of “Moderate Buy” and a consensus price target of $12.83.

Insider Buying and Selling at CryoPort

In related news, Director Robert J. Hariri sold 25,000 shares of CryoPort stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $9.71, for a total transaction of $242,750.00. Following the transaction, the director owned 51,275 shares in the company, valued at approximately $497,880.25. The trade was a 32.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert Stefanovich sold 9,300 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $8.67, for a total value of $80,631.00. Following the completion of the sale, the chief financial officer owned 207,213 shares of the company’s stock, valued at $1,796,536.71. The trade was a 4.30% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 39,300 shares of company stock worth $366,381 over the last 90 days. Insiders own 10.10% of the company’s stock.

CryoPort Stock Down 0.8%

CYRX stock opened at $8.76 on Friday. The business’s 50-day moving average price is $9.53 and its 200-day moving average price is $8.03. The stock has a market cap of $438.60 million, a P/E ratio of 6.59 and a beta of 1.58. The company has a quick ratio of 15.47, a current ratio of 16.24 and a debt-to-equity ratio of 0.39. CryoPort, Inc. has a twelve month low of $4.58 and a twelve month high of $11.44.

CryoPort (NASDAQ:CYRX) last released its earnings results on Tuesday, November 4th. The company reported ($0.18) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.05. CryoPort had a net margin of 37.21% and a negative return on equity of 9.79%. The company had revenue of $44.23 million for the quarter, compared to analysts’ expectations of $41.22 million. CryoPort has set its FY 2025 guidance at EPS. On average, equities research analysts forecast that CryoPort, Inc. will post -0.99 EPS for the current year.

About CryoPort

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.